Post-earnings recap
Reported
Wed, Jan 25, 2012
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
100%
Abbott Laboratories reported an EPS of $1.45, beating expectations slightly. However, the stock fell by 1.34% following the earnings report, indicating that investors may have been looking for more comprehensive insights or guidance, which were not provided in this release.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.45 | N/A | +0.69% |
| Revenue | N/A | N/A | N/A |
No transcript is on record, and the analysis is based on numerical results only.
—
Est. EPS
—
Est. Rev
—
Impl. Move
—